Author:
Li Xiao,Jin Ningyi,Lian Hai,Guan Goufang,Sun Lili,Li Xuemei,Zheng Hongling
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Dziadek S, Espinola C G, Kunz H. Synthetic glycopeptides for the development of antitumor vaccines. Aust J Chem, 2003, 56: 519–543
2. Haas C, Lulei M, Fournier P, et al. A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. Intl J Cancer, 2006, 118(3): 658–667
3. Mebatsion T, Koolen M J M, de Vaan L T C, et al. Newcastle Disease Virus (NDV) marker vaccine: An immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J Virol, 2002, 76(20): 10138–10146
4. Schirrmacher V, Haas C, Bonifer R, et al. Human tumor cell modification by virus infection: An efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Gene Ther, 1999, 6: 63–73
5. Bian H, Fournier P, Moormann R, et al. Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein. Intl J Oncol, 2005, 26: 431–439
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献